Gabriel S. Morris - 20 Dec 2021 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role: Chief Financial Officer, Director
Signature: /s/ Gabriel S Morris
Issuer symbol: IMMX
Transactions as of: 20 Dec 2021
Net transactions value: +$22,696
Form type: 4
Filing time: 20 Dec 2021, 15:15:18 UTC
Previous filing: 15 Dec 2021
Next filing: 18 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMMX	Common Stock	Conversion of derivative security	$62,999	+74,116		$0.8500	74,116	20 Dec 2021	Direct
transaction	IMMX	Common Stock	Conversion of derivative security	$104,998	+123,527		$0.8500	123,527	20 Dec 2021	See footnote	F3
transaction	IMMX	Common Stock	Conversion of derivative security	$104,700	+123,176	+100%	$0.8500	246,703	20 Dec 2021	See footnote	F3
transaction	IMMX	Common Stock	Purchase	$10,000	+2,000	+2.7%	$5.00	76,116	20 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMMX	Convertible Note	Conversion of derivative security	$60,000				0	20 Dec 2021	Common stock	74,116	$0.8500	Direct	F1
transaction	IMMX	Convertible Note	Conversion of derivative security	$100,000				0	20 Dec 2021	Common stock	123,527	$0.8500	See footnote	F2, F3
transaction	IMMX	Convertible Note	Conversion of derivative security	$100,000				0	20 Dec 2021	Common stock	123,176	$0.8500	See footnote	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 18, 2021, the Registrant issued the Reporting Person a note in the amount of $60,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.
F2	On March 18, 2021, the Registrant issued Alwaysraise LLC a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.
F3	Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity.
F4	On April 2, 2021, the Registrant issued Alwaysraise a note in the amount of $100,000 which is payable upon request of the majority holders of like tenure notes on or after March 1, 2023. Pursuant to the terms of the note, because the Registrant sold equity securities in its initial public offering resulting in proceeds of at least $10 million, the note automatically converted into shares of the Registrant's common stock.